Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04474301

Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

COVID-19 Infection COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Melanoma Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Germ Cell and Embryonal Neoplasms, Nerve Tissue Neuroectodermal Tumors Neuroendocrine Tumors Nevi and Melanomas Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Skin Diseases Skin Neoplasms Skin and Connective Tissue Diseases Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location status: Recruiting

Location contact

Lorenzo Cohen

CONTACT

[email protected]

Lorenzo Cohen

PRINCIPAL_INVESTIGATOR

About this study

PRIMARY OBJECTIVES:

I. Assess experiences during the COVID-19 pandemic (e.g., exposure, risk factors, testing, isolation, seropositivity, hospitalization, loss of family or friends); COVID-19-specific psychological distress (e.g., fear, anxiety and depressive symptoms); health, financial and social disruptions; perceived benefits and social support; and health-related quality of life (HRQoL) in melanoma patients who participated in protocol PA15-0336.

II. Evaluate the extent to which COVID-19 experiences are associated with COVID-19-specific psychological distress, health, financial and social disruptions, perceived benefits and social support, and HRQoL.

III. Evaluate the extent to which resiliency factors such as social support and perceived benefits moderate the effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL.

IV. Explore the association between prior lifestyle data collected as part of PA15-0336 and COVID-19-specific psychological distress and HRQoL.

OUTLINE:

Patients complete a survey over 10 minutes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who have signed consent for PA15-0336
  • Has an active email address and can be contacted via MyChart
  • Documentation of being alive per the cancer registry

Treatment and study plan

Survey Administration

Other

Complete survey

Primary outcomes

  1. Experiences during the COVID-19 pandemic

    Time frame: Survey completion Up to 2 months

    Including exposure, risk factors, testing, isolation, seropositivity, hospitalization, or loss of family or friends.

  2. COVID-19-specific psychological distress

    Time frame: Survey completion Up to 2 months

  3. COVID-19-specific health

    Time frame: Survey completion Up to 2 months

  4. COVID-19-specific financial and social disruptions

    Time frame: Survey completion Up to 2 months

  5. COVID-19-specific perceived benefits and social support

    Time frame: Survey completion Up to 2 months

  6. COVID-19-specific health related quality of life (HRQoL)

    Time frame: Survey completion Up to 2 months

  7. Effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL

    Time frame: Survey completion Up to 2 months

    Will evaluate the extent to which resiliency factors such as social support and perceived benefits moderate the effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL.

  8. Prior lifestyle data

    Time frame: Survey completion Up to 2 months

    Will explore the association between prior lifestyle data collected as part of PA15-0336 and COVID-19-specific psychological distress and HRQoL.

Study contacts

Contact information is provided by the study sponsor or research team.

Lorenzo Cohen

CONTACT

[email protected]

(713) 745-4260

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Well-Being and Quality of Life in Melanoma Patients During COVID-19 Pandemic

Important dates

Study start
2020
Primary completion
2026
Study completion
2026
First posted
Jul 16, 2020
Registry last updated
Apr 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.